Cord Blood Transplant: Procedure, Recovery and Results

A cord blood transplant is a type of stem cell transplant that uses donated blood-forming stem cells collected from an umbilical cord after birth. It may be used for selected blood cancers, bone marrow failure disorders, inherited immune conditions, and some genetic blood diseases when an appropriate donor source is available.

Overview: What Is a Cord Blood Transplant?

A cord blood transplant is a hematopoietic stem cell transplant that uses stem cells collected from the blood remaining in a newborn’s umbilical cord and placenta after delivery. These cells are stored in public cord blood banks and may later be selected for a person who needs a transplant. The donated cells can travel to the recipient’s bone marrow and begin producing new blood cells and immune cells.

The procedure is not surgery on the bone marrow. Instead, the donor stem cells are given through a vein, much like a blood transfusion. Before infusion, the recipient usually receives conditioning treatment with chemotherapy, radiation therapy, or both. This reduces diseased marrow cells, treats the underlying illness where appropriate, and makes room for the donor cells.

Cord blood is one source of donor stem cells. Others include bone marrow and peripheral blood stem cells from related or unrelated donors. A transplant team considers all suitable sources and recommends the option that offers the best balance of availability, matching, cell dose, expected disease control, and safety for the individual.

How It Works and Who May Be a Candidate

Healthy bone marrow makes red blood cells, white blood cells, and platelets. In certain cancers and blood or immune disorders, this system may be replaced by malignant cells, fail to produce adequate blood cells, or function incorrectly. A cord blood transplant aims to establish a new blood-forming and immune system from donor stem cells.

It may be considered for people with conditions such as acute leukemia, myelodysplastic syndromes, lymphoma in selected circumstances, severe aplastic anemia, inherited bone marrow failure syndromes, immune deficiencies, and certain inherited metabolic or blood disorders. The decision is highly individual and depends on whether transplant is likely to provide more benefit than non-transplant treatment.

Candidacy assessment includes the disease diagnosis and response to treatment, previous therapies, age, organ function, infection status, functional ability, and availability of suitable cord blood units. The transplant team also assesses human leukocyte antigen (HLA) matching and the number of stem cells in a unit. Cord blood can sometimes be used with less strict HLA matching than adult donor stem cells, but adequate cell dose remains particularly important.

In people with blood cancers, the transplant may be part of a broader treatment plan that includes leukemia care or other specialist oncology and hematology services. A transplant specialist can explain whether a cord blood source, another donor source, or a non-transplant approach is most appropriate.

The Cord Blood Transplant Procedure Step by Step

The cord blood transplant process begins with detailed testing and planning. Blood tests, heart and lung assessments, imaging when needed, dental review, infection screening, and discussions about fertility preservation may be arranged before treatment. A central venous catheter is commonly placed to allow chemotherapy, transfusions, medicines, fluids, and the stem cell infusion to be given safely.

Next comes conditioning. Depending on the disease and a person’s health, this may be intensive or reduced-intensity chemotherapy, sometimes combined with radiation therapy. Conditioning can take several days and is followed by a short rest period before infusion. It may cause fatigue, nausea, mouth soreness, diarrhea, hair loss, and temporarily very low blood counts; the care team provides supportive medicines and monitoring.

On transplant day, the selected frozen cord blood unit is thawed in a controlled laboratory process and infused through the central line. The cord blood transplant procedure generally takes less time than the preparation phase. Staff monitor temperature, blood pressure, breathing, and possible infusion reactions during and after the infusion.

Afterward, the person remains under close supervision while the donor cells settle in the marrow and begin producing new blood cells. This period is called engraftment. Comprehensive bone marrow transplant care includes donor selection, conditioning, transfusion support, infection prevention, and long-term follow-up tailored to the individual.

Recovery Timeline and Follow-Up Care

Cord blood recovery is gradual. During the first few weeks, blood counts are usually very low because the conditioning treatment has suppressed the existing marrow and the donor cells have not yet fully engrafted. People may stay in hospital during this high-risk period, although the exact setting and length of stay vary by treatment plan, complications, and local transplant practice.

White blood cell recovery often takes several weeks, and platelet recovery may take longer than after some other stem cell sources. Until counts improve, transfusions may be needed and the person is monitored closely for fever, bleeding, anemia, dehydration, nutritional problems, and treatment side effects. Medicines are commonly used to help prevent or treat infections and reduce the risk of graft-versus-host disease.

After discharge, frequent outpatient appointments continue. Blood tests track engraftment, organ function, medicine levels, and evidence of infection or disease recurrence. The immune system may take many months, and sometimes longer, to recover. Vaccinations are usually repeated on a schedule set by the transplant team once immune recovery is adequate.

Recovery also includes practical and emotional support. A temporary low-germ food approach may be advised by the care team, along with careful hand hygiene, avoidance of sick contacts, medication adherence, activity pacing, and prompt reporting of symptoms. A dietitian, physiotherapist, psychologist, pharmacist, and social worker may all contribute to recovery planning.

Benefits, Risks and Expected Results

A potential advantage of cord blood is availability. Units in public banks are already collected, tested, stored, and searchable, which may reduce the time needed to identify a donor source. Cord blood may also provide an option for people who do not have a fully matched related or unrelated adult donor, including people from populations underrepresented in donor registries.

However, cord blood units contain a limited number of cells. Engraftment can therefore be slower, especially for larger adults, and the early period of low blood counts can be prolonged. In some circumstances, clinicians may consider using two cord blood units or other strategies, but the approach depends on the patient, disease, and transplant center’s experience.

Important risks include serious bacterial, viral, or fungal infections; bleeding due to low platelets; anemia; organ effects from conditioning; infertility; cataracts after some treatments; and disease relapse. Graft-versus-host disease can occur when donor immune cells attack the recipient’s tissues. It may affect the skin, liver, gut, eyes, mouth, lungs, or other organs and requires specialist assessment and treatment.

Cord blood transplant success rate is not a single number that applies to everyone. Transplant teams evaluate outcomes using measures such as engraftment, remission, relapse, transplant-related mortality, overall survival, and quality of life. Results are influenced by the condition being treated, disease status at transplant, recipient age and health, infection history, HLA matching, cell dose, and complications after transplantation.

Practical Preparation, Prevention and Self-Care

There is no guaranteed way to prevent transplant complications, but preparation and self-care can reduce avoidable risks. Before treatment, people should share a complete medication list, allergies, vaccination history, past infections, and any symptoms with the transplant team. Smoking cessation, dental care when recommended, adequate nutrition, and safe physical activity can support readiness for treatment.

After transplant, infection precautions are especially important. The care team may recommend frequent handwashing, avoiding close exposure to people with contagious illnesses, following food-safety guidance, and using a mask in selected settings. It is important not to start supplements, herbal products, or over-the-counter medicines without checking first, as some can interact with transplant medicines or affect bleeding risk.

Caregivers often play a central role in transport, medicines, symptom monitoring, meals, and emotional support. Patients may find it helpful to keep a written record of temperature readings, medicines, fluid intake, symptoms, and appointment questions. Financial and travel planning should be discussed early with the hospital team because cord blood transplant cost can vary substantially according to country, conditioning regimen, hospital stay, complications, medicines, and follow-up requirements.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals provide assessment and treatment planning for international patients who may need stem cell transplantation. The recommended plan should always be based on a thorough clinical evaluation and discussion of alternatives.

When to Seek Medical Care

Anyone being evaluated for a cord blood transplant should contact the transplant team promptly if new symptoms develop before treatment, particularly fever, cough, shortness of breath, vomiting, diarrhea, urinary symptoms, new rash, unusual bruising, bleeding, or worsening weakness. These symptoms can have many causes, but infections and treatment complications need timely assessment in people with blood disorders or reduced immunity.

After transplant, follow the team’s emergency instructions carefully. A fever during periods of low white blood cells may require urgent evaluation even when the person otherwise feels well. Immediate medical care is also important for difficulty breathing, chest pain, confusion, severe headache, persistent vomiting, uncontrolled bleeding, severe abdominal pain, or a sudden widespread rash.

Appointments should not be delayed because routine monitoring can identify changes before symptoms become severe. Questions about medicines, diet, travel, vaccination, returning to work or school, and contact with children or pets should be directed to the transplant team, which can provide advice tailored to the person’s immune recovery and clinical situation.

Frequently asked questions

Is a cord blood transplant the same as a bone marrow transplant?

Both are types of hematopoietic stem cell transplant, meaning they replace or rebuild blood-forming cells. The main difference is the source of donor stem cells: cord blood comes from donated umbilical cord blood, while bone marrow cells are collected from a donor's marrow. The transplant team chooses the most suitable source based on matching, availability, cell dose, disease, and patient factors.

How long does it take to recover from a cord blood transplant?

The earliest phase of recovery generally takes weeks because new blood cells need time to engraft. Immune recovery often takes many months and can take longer in some people. Follow-up continues long term to monitor infections, graft-versus-host disease, organ health, vaccinations, and disease control.

Who can donate cord blood?

Cord blood is donated voluntarily after a healthy birth through participating public cord blood banks. Collection takes place after the baby is delivered and the cord is clamped, and it does not interfere with routine newborn care. Donation eligibility and collection procedures vary by country and bank.

Is cord blood transplant painful?

The stem cell infusion itself is typically similar to receiving a transfusion and is not usually painful. However, conditioning treatment and recovery can cause side effects such as fatigue, nausea, mouth soreness, and low blood counts. The transplant team provides medicines and supportive care to manage symptoms as safely as possible.

What affects cord blood transplant success rate?

Outcomes depend on many factors, including the disease being treated, whether it is controlled at transplant, the person's age and overall health, cell dose, HLA match, and complications such as infection or graft-versus-host disease. A transplant specialist can explain the expected benefits and risks using information specific to the individual's diagnosis and treatment history.

Does insurance cover cord blood transplant cost?

Coverage depends on the country, insurance plan, diagnosis, approved treatment setting, and whether a transplant is considered medically necessary. Costs may include testing, donor-unit processing, conditioning, hospital care, medicines, transfusions, and follow-up. Patients should ask the hospital financial counseling team and their insurer for an individualized coverage review before treatment when possible.

References

• World Health Organization
• National Cancer Institute
• American Society of Hematology
• European Society for Blood and Marrow Transplantation
• National Marrow Donor Program

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.